Advertisement

Topics

NantOmics, LLC Company Profile

02:21 EDT 23rd October 2018 | BioPortfolio

NantOmics, a member of the NantWorks ecosystem of companies, delivers molecular analysis capabilities with the intent of providing actionable intelligence and molecularly driven decision support for cancer patients and their providers at the point of care. NantOmics is the first molecular testing company to pioneer an integrated approach to unearthing the genomic and proteomic variances that initiate and drive cancer, by analyzing both normal and tumor cells from the same patient and following identified variances through from DNA to RNA to protein to drug. NantOmics has a highly scalable cloud-based infrastructure capable of storing and processing thousands of genomes a day, computing genomic variances in near real-time, and correlating proteomic pathway analysis with quantitative multi-plexed protein expression analysis from the same micro-dissected tumor sample used for genomic analysis. For more information please visit www.nantomics.com and follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.


News Articles [17 Associated News Articles listed on BioPortfolio]

Using Technology that Powers GPS Cancer, Scientists have Developed Fresh Insights into the Driving Mechanisms of a Rare Skin Cancer

CULVER CITY, Calif.–(BUSINESS WIRE)–New, peer-reviewed research utilizing NantOmics technology, which powers NantHealth’s (NASDAQ: NH) GPS Cancer ® is giving scientists fresh insights i...

NantOmics to Share Results of NantOmics Pharmacogenomics Test at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Results to be presented during the developmental therapeutics session at the ASCO 2018 Annual Meeting NantWorks, LLC today announced that its affiliate company, NantOmi...

NantOmics to Present Data for Mutational Processes and Response to Neoadjuvant Chemotherapy in ...

The results to be presented during the breast cancer session at ASCO 2018 Annual Meeting Read more...

NantOmics to Report Data on Cardiac Function in Sarcoma Patients Receiving Aldoxorubicin with ...

Results to be presented during the sarcoma session at the ASCO 2018 Annual Meeting Read more...

NantOmics to Report Data on Cardiac Function in Sarcoma Patients Receiving Aldoxorubicin with Doxorubicin Equivalent Doses over 1000 mg/m2 at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Results to be presented during the sarcoma session at the ASCO 2018 Annual Meeting NantWorks, LLC today announced that its affiliate company, NantOmics, LLC, the...

NantOmics to Present Results of DESMOPAZ Study from French Sarcoma Group (FSG) at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Results to be presented during the sarcoma session at the ASCO 2018 Annual Meeting NantWorks, LLC today announced that its affiliate company, NantOmics, LLC, the...

Using the Technology That Powers GPS Cancer™, Scientists Have Developed Fresh Insights into the Driving Mechanisms of a Rare Skin Cancer

Peer-reviewed research utilizing NantOmics technology gives scientists fresh insights into driving mechanisms behind a form of rare skin cancer New, peer-reviewed resea...

NantOmics to Present Potential Treatment Options for SCLC Patients with Multiplexed Clinical Proteomic Testing at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Results to be presented during the lung cancer—non-small cell local-regional/small cell/other thoracic cancers session at the ASCO 2018 Annual Meeting NantWorks, ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

NantOmics LLC

NantOmics LLC, is a leading medical diagnostic company dedicated to providing actionable intelligence and molecularly driven decision support for cancer patients and their provide...

NantOmics, LLC

NantOmics, a member of the NantWorks ecosystem of companies, delivers molecular analysis capabilities with the intent of providing actionable intelligence and molecularly driven d...

More Information about "NantOmics, LLC" on BioPortfolio

We have published hundreds of NantOmics, LLC news stories on BioPortfolio along with dozens of NantOmics, LLC Clinical Trials and PubMed Articles about NantOmics, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NantOmics, LLC Companies in our database. You can also find out about relevant NantOmics, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record